Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1010 | 1228 | 981 | 1159 | 1718 | - |
Fund Return | 0.97% | 22.81% | -1.93% | 5.05% | 11.43% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
001668 | 20.35B | 8.59 | 2.96 | - | ||
China Universal Consumer Industries | 13.91B | 6.83 | -14.16 | 17.24 | ||
China Universal Selective Mixed Sec | 9.46B | 9.73 | -14.13 | 12.29 | ||
China Universal Blue Chip Equity Fu | 4.62B | 1.80 | -15.39 | 12.79 | ||
China Universal CSI 300 Dynamic Str | 4.21B | 7.52 | -1.09 | 10.07 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HuaShang New Trend Selected mix | 10.46B | 6.09 | 12.26 | 24.21 | ||
AEGON Industrial New View Intrv | 9.23B | 1.69 | -5.98 | - | ||
Fullgoal New Power Alloc A | 5.88B | -4.02 | -4.95 | - | ||
Fullgoal New Power Alloc C | 5.88B | -4.17 | -5.42 | - | ||
QHKY New Economy Flexible Alloc Fd | 5.47B | -12.22 | 5.25 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 10.06 | 46.48 | -0.90% | |
Kelun Pharm A | CNE100000PW7 | 6.36 | 34.74 | -0.14% | |
Salubris Pharm A | CNE100000FW8 | 6.03 | 31.18 | -1.14% | |
Shanghai MicroPort EP Medtech | CNE100005PG9 | 4.46 | 25.75 | -1.79% | |
RemeGen | CNE100005B03 | 4.26 | 56.00 | -0.78% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review